Tumor Immunology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TORONTO & SAN FRANCISCO, February 14, 2024--Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel first-in-class medicines for unmet needs in cancer, today announced the formation of a Scientific Advisory Board comprised of prominent oncology leaders and drug developers. The SAB will work closely with Treadwell to advance the company’s pipeline of small molecules, biologics and cell therapies.

The combination of a pair of drugs ‘awarded’ the Nobel Prize in Medicine reduces tumors in 28% of patients with aggressive melanoma

Highlights from NPR, Salon, CNN and others.

Positive results from Phase 2 of this cancer treatment trial showed a reduced risk of death and recurrence in patients. What is the Moderna melanoma vaccine? What is Keytruda? Is there a vaccine for cancer?

Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of skin cancer, saw their cancer improve after treatment with the immunotherapy drug pembrolizumab in a recent clinical trial. These results from the S1512 trial are being delivered in an oral presentation at the clinical trials plenary session of the 2023 annual meeting of the American Association for Cancer Research (AACR) in Orlando, Florida, on April 16th.